| Report ID | 267743 |
| Drug Identification Number | 00042579 |
| Brand name | MAXIDEX |
| Common or Proper name | MAXIDEX OINTMENT 3.5 G |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE |
| Strength(s) | 0.1% |
| Dosage form(s) | OINTMENT |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 3.5 G |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-10-02 |
| Actual start date | 2025-09-25 |
| Estimated end date | 2025-12-03 |
| Actual end date | 2025-12-18 |
| Shortage status | Resolved |
| Updated date | 2026-01-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2026-01-05 | French | Compare |
| v8 | 2026-01-05 | English | Compare |
| v7 | 2025-11-10 | French | Compare |
| v6 | 2025-11-10 | English | Compare |
| v5 | 2025-09-29 | French | Compare |
| v4 | 2025-09-29 | English | Compare |
| v3 | 2025-09-26 | English | Compare |
| v2 | 2025-09-24 | French | Compare |
| v1 | 2025-09-24 | English | Compare |
Showing 1 to 9 of 9